As states implement the CDC ACIP's COVID-19 vaccination priorities, they are revising them as needed based on federal, state, and local conditions. Here is a recent snapshot.
All News

What is the drug of choice in a patient who is taking aspirin for secondary prevention of stroke? Ibuprofen? Celecoxib? Other? Plus 6 more questions on NSAID use in primary care.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

FDA approved the fixed-dose combination heart failure drug sacubitril/valsartan to reduce risk of CV death and hospitalization in patients with chronic heart failure.

A new review of >60 000 patients with diabetes found CGM use during the early weeks of the COVID-19 pandemic improved their time in range.

Pain is a common complication of COVID-19 infection, during the illness and afterwards. Click through this summary of new data on acute pain and risk for persistent pain from COVID-19.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Early in the pandemic, Dr MacArthur's family worried he would get infected at work and bring the virus home. COVID-19 did come close to home and a few lessons were learned.

New research suggests obesity is responsible for 30%-53% of new type 2 diabetes cases in the US annually.

To ensure COVID-19 vaccination priority for the sickest CVD patients, the ACC statement identifies highest risk conditions within CVD to aid clinician decision making.

Global confirmed cases of COVID-19 have surpassed 109 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

As a group, Americans who want to wait and see how the COVID-19 vaccine works for others are younger and more diverse than those who want it ASAP.

Global confirmed cases of COVID-19 have surpassed 108 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Authors of 2 large cannabis-user database analyses discuss the possible reasons for observed dose increase over time by individuals using inhaled cannabis for pain relief.

Double-masking found to reduce SARS-CoV-2 spread, FDA decision on antibody cocktail for treatment of COVID-19, and 8 more news briefs summarized for primary care.
In animal models, pain relief from cannabis has been found to be greater in females; new research on pain relief from inhaled cannabis in regular users found something different.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

A new survey of patients with asthma who use cannabis finds smoking and vaping preferred routes and that physicians rarely inquire about marijuana use.

In the first study of its kind, pre-existing eosinophilia was protective from COVID-19-related hospital admission and mortality in patients with asthma.
Research on pain relief from use of medical cannabis poses myriad challenges. Veteran researchers discuss 2 new studies based on a deep well of user data.
